Vacci-nation: A case study in health and prosperity

Article

Vaccines have been integral to health and prosperity in the last three centuries.

The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.

Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.

On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.

Related items

  1. A busy high street in Kingston-upon-Thames, London. Shoppers walking beneath multi-coloured bunting

    Bricks vs clicks: The case for an online sales tax

    It's time to rethink how we tax retail.
  2. A close up photo of a bricklayer smoothing cement between a layer of red bricks

    Beyond boom and bust: The supply case for social housing

    How the government can use social housing to unlock housing supply and demand.
  3. A stack of large shipping containers painted with the UK and EU flags

    Aligning for growth? The benefits of an EU-UK mutual recognition agreement

    Scoping the potential next frontier of a deepening relationship between the UK and the EU.